In a filing, Dyne Therapeutics Inc revealed its Director Kersten Dirk unloaded Company’s shares for reported $0.47 million on Oct 18 ’24. In the deal valued at $35.16 per share,13,414 shares were sold. As a result of this transaction, Kersten Dirk now holds 73,225 shares worth roughly $2.25 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Kersten Dirk sold 121 shares, generating $4,242 in total proceeds. Upon selling the shares at $35.06, the Director now owns 73,104 shares.
Before that, Kersten Dirk sold 23,671 shares. Dyne Therapeutics Inc shares valued at $836,770 were divested by the Director at a price of $35.35 per share. As a result of the transaction, Kersten Dirk now holds 99,652 shares, worth roughly $3.06 million.
JP Morgan downgraded its Dyne Therapeutics Inc [DYN] rating to a Neutral from a an Overweight in a research note published on October 24, 2024; the price target was decreased to $35 from $43. A number of analysts have revised their coverage, including Chardan Capital Markets’s analysts, who remained covering the stock and in late May has reiterated a ‘”a Buy”‘ rating for it. Morgan Stanley began covering DYN with “an Overweight” recommendation on April 30, 2024. H.C. Wainwright started covering the stock on February 20, 2024. It rated DYN as “a Buy”.
Price Performance Review of DYN
On Friday, Dyne Therapeutics Inc [NASDAQ:DYN] saw its stock fall -1.19% to $30.73. Over the last five days, the stock has lost -12.80%. Dyne Therapeutics Inc shares have risen nearly 131.05% since the year began. Nevertheless, the stocks have risen 361.41% over the past one year. While a 52-week high of $47.45 was reached on 08/20/24, a 52-week low of $6.40 was recorded on 01/03/24. SMA at 50 days reached $36.32, while 200 days put it at $31.35.
Levels Of Support And Resistance For DYN Stock
The 24-hour chart illustrates a support level at 30.32, which if violated will result in even more drops to 29.92. On the upside, there is a resistance level at 31.48. A further resistance level may holdings at 32.24. The Relative Strength Index (RSI) on the 14-day chart is 37.19, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.80, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.85%. Stochastics %K at 11.02% indicates the stock is a buying.
How much short interest is there in Dyne Therapeutics Inc?
A steep rise in short interest was recorded in Dyne Therapeutics Inc stocks on 2024-10-15, growing by 1.45 million shares to a total of 9.11 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 7.66 million shares. There was a rise of 15.92%, which implies that there is a positive sentiment for the stock.
